APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rheolytic Thrombectomy

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Rheolytic Thrombectomy Market Analysis and Forecast 2026-2032

Report ID 17444356035 July 2026171 pages

Choose your research edition.

Industry ResearchRheolytic Thrombectomy Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Rheolytic Thrombectomy Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Rheolytic Thrombectomy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rheolytic Thrombectomy Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Rheolytic Thrombectomy Market Analysis and Forecast 2026-2032171 pages · $4,950 USD

Market perspective

The global Rheolytic Thrombectomy market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Rheolytic Thrombectomy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rheolytic Thrombectomy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rheolytic Thrombectomy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rheolytic Thrombectomy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Rheolytic Thrombectomy include Abbott Laboratories, Koninklijke Philips N.V., Terumo Corporation, Boston Scientific Group, Medtronic plc, AngioDynamics, Penumbra Inc., Stryker Corporation and Teleflex Incorporated, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Rheolytic Thrombectomy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rheolytic Thrombectomy, also provides the revenue of main regions and countries. Of the upcoming market potential for Rheolytic Thrombectomy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rheolytic Thrombectomy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rheolytic Thrombectomy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Rheolytic Thrombectomy revenue, projected growth trends, production technology, application and end-user industry.

Rheolytic Thrombectomy Segment by Company

Abbott Laboratories

Koninklijke Philips N.V.

Terumo Corporation

Boston Scientific Group

Medtronic plc

AngioDynamics

Penumbra Inc.

Stryker Corporation

Teleflex Incorporated

Johnson and Johnson

Rheolytic Thrombectomy Segment by Type

Automated Devices

Manual Devices

Rheolytic Thrombectomy Segment by Application

Peripheral Diseases

Coronary Disease

Neural Diseases

Rheolytic Thrombectomy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rheolytic Thrombectomy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rheolytic Thrombectomy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rheolytic Thrombectomy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Rheolytic Thrombectomy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Rheolytic Thrombectomy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rheolytic Thrombectomy revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rheolytic Thrombectomy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Automated Devices Major Player Table 3. Manual Devices Major Player Table 4. Global Rheolytic Thrombectomy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Peripheral Diseases Major Player Table 6. Coronary Disease Major Player Table 7. Neural Diseases Major Player Table 8. Rheolytic Thrombectomy Industry Trends Table 9. Rheolytic Thrombectomy Industry Drivers Table 10. Rheolytic Thrombectomy Industry Opportunities and Challenges Table 11. Rheolytic Thrombectomy Industry Restraints Table 12. Global Rheolytic Thrombectomy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Rheolytic Thrombectomy Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Rheolytic Thrombectomy Market Share by Region (2021-2026) Table 15. Global Rheolytic Thrombectomy Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Rheolytic Thrombectomy Market Share by Region (2027-2032) Table 17. Global Rheolytic Thrombectomy Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Rheolytic Thrombectomy Revenue Market Share by Players (2021-2026) Table 19. Global Rheolytic Thrombectomy Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Rheolytic Thrombectomy Key Players Headquarters & Area Served Table 21. Global Rheolytic Thrombectomy Players, Product Type & Application Table 22. Global Rheolytic Thrombectomy Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Rheolytic Thrombectomy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Rheolytic Thrombectomy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Rheolytic Thrombectomy Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Rheolytic Thrombectomy Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Rheolytic Thrombectomy Revenue Market Share by Type (2021-2026) Table 29. Global Rheolytic Thrombectomy Revenue Market Share by Type (2027-2032) Table 30. Global Rheolytic Thrombectomy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Rheolytic Thrombectomy Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Rheolytic Thrombectomy Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Rheolytic Thrombectomy Revenue Market Share by Application (2021-2026) Table 34. Global Rheolytic Thrombectomy Revenue Market Share by Application (2027-2032) Table 35. Abbott Laboratories Company Information Table 36. Abbott Laboratories Business Overview Table 37. Abbott Laboratories Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Abbott Laboratories Rheolytic Thrombectomy Product Portfolio Table 39. Abbott Laboratories Recent Development Table 40. Koninklijke Philips N.V. Company Information Table 41. Koninklijke Philips N.V. Business Overview Table 42. Koninklijke Philips N.V. Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Koninklijke Philips N.V. Rheolytic Thrombectomy Product Portfolio Table 44. Koninklijke Philips N.V. Recent Development Table 45. Terumo Corporation Company Information Table 46. Terumo Corporation Business Overview Table 47. Terumo Corporation Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Terumo Corporation Rheolytic Thrombectomy Product Portfolio Table 49. Terumo Corporation Recent Development Table 50. Boston Scientific Group Company Information Table 51. Boston Scientific Group Business Overview Table 52. Boston Scientific Group Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Boston Scientific Group Rheolytic Thrombectomy Product Portfolio Table 54. Boston Scientific Group Recent Development Table 55. Medtronic plc Company Information Table 56. Medtronic plc Business Overview Table 57. Medtronic plc Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Medtronic plc Rheolytic Thrombectomy Product Portfolio Table 59. Medtronic plc Recent Development Table 60. AngioDynamics Company Information Table 61. AngioDynamics Business Overview Table 62. AngioDynamics Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. AngioDynamics Rheolytic Thrombectomy Product Portfolio Table 64. AngioDynamics Recent Development Table 65. Penumbra Inc. Company Information Table 66. Penumbra Inc. Business Overview Table 67. Penumbra Inc. Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Penumbra Inc. Rheolytic Thrombectomy Product Portfolio Table 69. Penumbra Inc. Recent Development Table 70. Stryker Corporation Company Information Table 71. Stryker Corporation Business Overview Table 72. Stryker Corporation Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Stryker Corporation Rheolytic Thrombectomy Product Portfolio Table 74. Stryker Corporation Recent Development Table 75. Teleflex Incorporated Company Information Table 76. Teleflex Incorporated Business Overview Table 77. Teleflex Incorporated Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Teleflex Incorporated Rheolytic Thrombectomy Product Portfolio Table 79. Teleflex Incorporated Recent Development Table 80. Johnson and Johnson Company Information Table 81. Johnson and Johnson Business Overview Table 82. Johnson and Johnson Rheolytic Thrombectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Johnson and Johnson Rheolytic Thrombectomy Product Portfolio Table 84. Johnson and Johnson Recent Development Table 85. North America Rheolytic Thrombectomy Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Rheolytic Thrombectomy Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Rheolytic Thrombectomy Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Rheolytic Thrombectomy Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Rheolytic Thrombectomy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Rheolytic Thrombectomy Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Rheolytic Thrombectomy Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe Rheolytic Thrombectomy Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Rheolytic Thrombectomy Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Rheolytic Thrombectomy Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Rheolytic Thrombectomy Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Rheolytic Thrombectomy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Rheolytic Thrombectomy Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe Rheolytic Thrombectomy Revenue by Country (US$ Million) & (2027-2032) Table 99. China Rheolytic Thrombectomy Revenue by Type (2021-2026) & (US$ Million) Table 100. China Rheolytic Thrombectomy Revenue by Type (2027-2032) & (US$ Million) Table 101. China Rheolytic Thrombectomy Revenue by Application (2021-2026) & (US$ Million) Table 102. China Rheolytic Thrombectomy Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Rheolytic Thrombectomy Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia Rheolytic Thrombectomy Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia Rheolytic Thrombectomy Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia Rheolytic Thrombectomy Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Rheolytic Thrombectomy Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Rheolytic Thrombectomy Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia Rheolytic Thrombectomy Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA Rheolytic Thrombectomy Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA Rheolytic Thrombectomy Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA Rheolytic Thrombectomy Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA Rheolytic Thrombectomy Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA Rheolytic Thrombectomy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA Rheolytic Thrombectomy Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA Rheolytic Thrombectomy Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Rheolytic Thrombectomy Image Figure 2. Global Rheolytic Thrombectomy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rheolytic Thrombectomy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Automated Devices Image Figure 5. Manual Devices Image Figure 6. Global Rheolytic Thrombectomy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Rheolytic Thrombectomy Market Size Share 2021 VS 2025 VS 2032 Figure 8. Peripheral Diseases Image Figure 9. Coronary Disease Image Figure 10. Neural Diseases Image Figure 11. Global Rheolytic Thrombectomy Market Size (US$ Million) & (2021-2032) Figure 12. Global Rheolytic Thrombectomy Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Rheolytic Thrombectomy Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Rheolytic Thrombectomy Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Rheolytic Thrombectomy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Rheolytic Thrombectomy Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Rheolytic Thrombectomy Revenue Market Share by Type (2021-2032) Figure 19. Global Rheolytic Thrombectomy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Rheolytic Thrombectomy Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Rheolytic Thrombectomy Revenue Market Share by Application (2021-2032) Figure 22. North America Rheolytic Thrombectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Rheolytic Thrombectomy Revenue Share by Type (2021-2032) Figure 24. North America Rheolytic Thrombectomy Revenue Share by Application (2021-2032) Figure 25. North America Rheolytic Thrombectomy Revenue Share by Country (2021-2032) Figure 26. United States Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Rheolytic Thrombectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Rheolytic Thrombectomy Revenue Share by Type (2021-2032) Figure 31. Europe Rheolytic Thrombectomy Revenue Share by Application (2021-2032) Figure 32. Europe Rheolytic Thrombectomy Revenue Share by Country (2021-2032) Figure 33. Germany Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Rheolytic Thrombectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Rheolytic Thrombectomy Revenue Share by Type (2021-2032) Figure 43. China Rheolytic Thrombectomy Revenue Share by Application (2021-2032) Figure 44. Asia Rheolytic Thrombectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Rheolytic Thrombectomy Revenue Share by Type (2021-2032) Figure 46. Asia Rheolytic Thrombectomy Revenue Share by Application (2021-2032) Figure 47. Asia Rheolytic Thrombectomy Revenue Share by Region (2021-2032) Figure 48. Japan Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Rheolytic Thrombectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Rheolytic Thrombectomy Revenue Share by Type (2021-2032) Figure 56. SAMEA Rheolytic Thrombectomy Revenue Share by Application (2021-2032) Figure 57. SAMEA Rheolytic Thrombectomy Revenue Share by Country (2021-2032) Figure 58. Brazil Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Rheolytic Thrombectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Automated Devices
  • Manual Devices
Applications
  • Peripheral Diseases
  • Coronary Disease
  • Neural Diseases
Companies covered
  • Abbott Laboratories
  • Koninklijke Philips N.V.
  • Terumo Corporation
  • Boston Scientific Group
  • Medtronic plc
  • AngioDynamics
  • Penumbra Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Johnson and Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rheolytic Thrombectomy Market by Type
  3. 1.2.1 Global Rheolytic Thrombectomy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Automated Devices
  5. 1.2.3 Manual Devices
  6. 1.3 Rheolytic Thrombectomy Market by Application
  7. 1.3.1 Global Rheolytic Thrombectomy Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Peripheral Diseases
  9. 1.3.3 Coronary Disease
  10. 1.3.4 Neural Diseases
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Rheolytic Thrombectomy Market Dynamics
  1. 2.1 Rheolytic Thrombectomy Industry Trends
  2. 2.2 Rheolytic Thrombectomy Industry Drivers
  3. 2.3 Rheolytic Thrombectomy Industry Opportunities and Challenges
  4. 2.4 Rheolytic Thrombectomy Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Rheolytic Thrombectomy Market Perspective (2021-2032)
  2. 3.2 Global Rheolytic Thrombectomy Growth Trends by Region
  3. 3.2.1 Global Rheolytic Thrombectomy Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rheolytic Thrombectomy Market Size by Region (2021-2026)
  5. 3.2.3 Global Rheolytic Thrombectomy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Rheolytic Thrombectomy Revenue by Players
  2. 4.1.1 Global Rheolytic Thrombectomy Revenue by Players (2021-2026)
  3. 4.1.2 Global Rheolytic Thrombectomy Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Rheolytic Thrombectomy Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rheolytic Thrombectomy Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Rheolytic Thrombectomy Key Players Headquarters & Area Served
  7. 4.4 Global Rheolytic Thrombectomy Players, Product Type & Application
  8. 4.5 Global Rheolytic Thrombectomy Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Rheolytic Thrombectomy Market CR5 and HHI
  11. 4.6.3 2025 Rheolytic Thrombectomy Tier 1, Tier 2, and Tier 3
5 Rheolytic Thrombectomy Market Size by Type
  1. 5.1 Global Rheolytic Thrombectomy Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Rheolytic Thrombectomy Revenue by Type (2021-2032)
  3. 5.3 Global Rheolytic Thrombectomy Revenue Market Share by Type (2021-2032)
6 Rheolytic Thrombectomy Market Size by Application
  1. 6.1 Global Rheolytic Thrombectomy Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Rheolytic Thrombectomy Revenue by Application (2021-2032)
  3. 6.3 Global Rheolytic Thrombectomy Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott Laboratories
  2. 7.1.1 Abbott Laboratories Company Information
  3. 7.1.2 Abbott Laboratories Business Overview
  4. 7.1.3 Abbott Laboratories Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Laboratories Rheolytic Thrombectomy Product Portfolio
  6. 7.1.5 Abbott Laboratories Recent Developments
  7. 7.2 Koninklijke Philips N.V.
  8. 7.2.1 Koninklijke Philips N.V. Company Information
  9. 7.2.2 Koninklijke Philips N.V. Business Overview
  10. 7.2.3 Koninklijke Philips N.V. Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Koninklijke Philips N.V. Rheolytic Thrombectomy Product Portfolio
  12. 7.2.5 Koninklijke Philips N.V. Recent Developments
  13. 7.3 Terumo Corporation
  14. 7.3.1 Terumo Corporation Company Information
  15. 7.3.2 Terumo Corporation Business Overview
  16. 7.3.3 Terumo Corporation Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Terumo Corporation Rheolytic Thrombectomy Product Portfolio
  18. 7.3.5 Terumo Corporation Recent Developments
  19. 7.4 Boston Scientific Group
  20. 7.4.1 Boston Scientific Group Company Information
  21. 7.4.2 Boston Scientific Group Business Overview
  22. 7.4.3 Boston Scientific Group Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Boston Scientific Group Rheolytic Thrombectomy Product Portfolio
  24. 7.4.5 Boston Scientific Group Recent Developments
  25. 7.5 Medtronic plc
  26. 7.5.1 Medtronic plc Company Information
  27. 7.5.2 Medtronic plc Business Overview
  28. 7.5.3 Medtronic plc Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Medtronic plc Rheolytic Thrombectomy Product Portfolio
  30. 7.5.5 Medtronic plc Recent Developments
  31. 7.6 AngioDynamics
  32. 7.6.1 AngioDynamics Company Information
  33. 7.6.2 AngioDynamics Business Overview
  34. 7.6.3 AngioDynamics Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  35. 7.6.4 AngioDynamics Rheolytic Thrombectomy Product Portfolio
  36. 7.6.5 AngioDynamics Recent Developments
  37. 7.7 Penumbra Inc.
  38. 7.7.1 Penumbra Inc. Company Information
  39. 7.7.2 Penumbra Inc. Business Overview
  40. 7.7.3 Penumbra Inc. Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Penumbra Inc. Rheolytic Thrombectomy Product Portfolio
  42. 7.7.5 Penumbra Inc. Recent Developments
  43. 7.8 Stryker Corporation
  44. 7.8.1 Stryker Corporation Company Information
  45. 7.8.2 Stryker Corporation Business Overview
  46. 7.8.3 Stryker Corporation Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Stryker Corporation Rheolytic Thrombectomy Product Portfolio
  48. 7.8.5 Stryker Corporation Recent Developments
  49. 7.9 Teleflex Incorporated
  50. 7.9.1 Teleflex Incorporated Company Information
  51. 7.9.2 Teleflex Incorporated Business Overview
  52. 7.9.3 Teleflex Incorporated Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Teleflex Incorporated Rheolytic Thrombectomy Product Portfolio
  54. 7.9.5 Teleflex Incorporated Recent Developments
  55. 7.10 Johnson and Johnson
  56. 7.10.1 Johnson and Johnson Company Information
  57. 7.10.2 Johnson and Johnson Business Overview
  58. 7.10.3 Johnson and Johnson Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Johnson and Johnson Rheolytic Thrombectomy Product Portfolio
  60. 7.10.5 Johnson and Johnson Recent Developments
8 North America
  1. 8.1 North America Rheolytic Thrombectomy Revenue (2021-2032)
  2. 8.2 North America Rheolytic Thrombectomy Revenue by Type (2021-2032)
  3. 8.2.1 North America Rheolytic Thrombectomy Revenue by Type (2021-2026)
  4. 8.2.2 North America Rheolytic Thrombectomy Revenue by Type (2027-2032)
  5. 8.3 North America Rheolytic Thrombectomy Revenue Share by Type (2021-2032)
  6. 8.4 North America Rheolytic Thrombectomy Revenue by Application (2021-2032)
  7. 8.4.1 North America Rheolytic Thrombectomy Revenue by Application (2021-2026)
  8. 8.4.2 North America Rheolytic Thrombectomy Revenue by Application (2027-2032)
  9. 8.5 North America Rheolytic Thrombectomy Revenue Share by Application (2021-2032)
  10. 8.6 North America Rheolytic Thrombectomy Revenue by Country
  11. 8.6.1 North America Rheolytic Thrombectomy Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Rheolytic Thrombectomy Revenue by Country (2021-2026)
  13. 8.6.3 North America Rheolytic Thrombectomy Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Rheolytic Thrombectomy Revenue (2021-2032)
  2. 9.2 Europe Rheolytic Thrombectomy Revenue by Type (2021-2032)
  3. 9.2.1 Europe Rheolytic Thrombectomy Revenue by Type (2021-2026)
  4. 9.2.2 Europe Rheolytic Thrombectomy Revenue by Type (2027-2032)
  5. 9.3 Europe Rheolytic Thrombectomy Revenue Share by Type (2021-2032)
  6. 9.4 Europe Rheolytic Thrombectomy Revenue by Application (2021-2032)
  7. 9.4.1 Europe Rheolytic Thrombectomy Revenue by Application (2021-2026)
  8. 9.4.2 Europe Rheolytic Thrombectomy Revenue by Application (2027-2032)
  9. 9.5 Europe Rheolytic Thrombectomy Revenue Share by Application (2021-2032)
  10. 9.6 Europe Rheolytic Thrombectomy Revenue by Country
  11. 9.6.1 Europe Rheolytic Thrombectomy Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Rheolytic Thrombectomy Revenue by Country (2021-2026)
  13. 9.6.3 Europe Rheolytic Thrombectomy Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Rheolytic Thrombectomy Revenue (2021-2032)
  2. 10.2 China Rheolytic Thrombectomy Revenue by Type (2021-2032)
  3. 10.2.1 China Rheolytic Thrombectomy Revenue by Type (2021-2026)
  4. 10.2.2 China Rheolytic Thrombectomy Revenue by Type (2027-2032)
  5. 10.3 China Rheolytic Thrombectomy Revenue Share by Type (2021-2032)
  6. 10.4 China Rheolytic Thrombectomy Revenue by Application (2021-2032)
  7. 10.4.1 China Rheolytic Thrombectomy Revenue by Application (2021-2026)
  8. 10.4.2 China Rheolytic Thrombectomy Revenue by Application (2027-2032)
  9. 10.5 China Rheolytic Thrombectomy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rheolytic Thrombectomy Revenue (2021-2032)
  2. 11.2 Asia Rheolytic Thrombectomy Revenue by Type (2021-2032)
  3. 11.2.1 Asia Rheolytic Thrombectomy Revenue by Type (2021-2026)
  4. 11.2.2 Asia Rheolytic Thrombectomy Revenue by Type (2027-2032)
  5. 11.3 Asia Rheolytic Thrombectomy Revenue Share by Type (2021-2032)
  6. 11.4 Asia Rheolytic Thrombectomy Revenue by Application (2021-2032)
  7. 11.4.1 Asia Rheolytic Thrombectomy Revenue by Application (2021-2026)
  8. 11.4.2 Asia Rheolytic Thrombectomy Revenue by Application (2027-2032)
  9. 11.5 Asia Rheolytic Thrombectomy Revenue Share by Application (2021-2032)
  10. 11.6 Asia Rheolytic Thrombectomy Revenue by Country
  11. 11.6.1 Asia Rheolytic Thrombectomy Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Rheolytic Thrombectomy Revenue by Country (2021-2026)
  13. 11.6.3 Asia Rheolytic Thrombectomy Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rheolytic Thrombectomy Revenue (2021-2032)
  2. 12.2 SAMEA Rheolytic Thrombectomy Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Rheolytic Thrombectomy Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Rheolytic Thrombectomy Revenue by Type (2027-2032)
  5. 12.3 SAMEA Rheolytic Thrombectomy Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Rheolytic Thrombectomy Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Rheolytic Thrombectomy Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Rheolytic Thrombectomy Revenue by Application (2027-2032)
  9. 12.5 SAMEA Rheolytic Thrombectomy Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Rheolytic Thrombectomy Revenue by Country
  11. 12.6.1 SAMEA Rheolytic Thrombectomy Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Rheolytic Thrombectomy Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Rheolytic Thrombectomy Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst